逐批进口许可:从注册证到清关的单据链条
Updated: 2026-11-09 · GRZAN Regulatory Team · Verification date 2026-10-20
I. Key takeaways
Only registered medical devices may be imported into Cambodia for sale. Holding a registration number does not mean goods can ship directly — Cambodia operates a per-shipment import licence system: after obtaining the registration certificate, an import licence for each consignment must be applied for from the competent authority before that consignment is imported.
The customs document chain typically includes the product registration certificate, the import licence for that consignment, the commercial invoice, the packing list and a certificate of origin, plus a quality certificate conforming to international standards. On arrival at the port, customs clearance is completed against the import licence and the other documents, with the applicable customs duty and VAT payable; duty rates are determined by the specific HS code.
GRZAN note: importation involves 2 procedures (product registration number + per-shipment import licence); customs documents run to at least 5 categories; as an ASEAN member, Cambodia also requires attention to alignment with ASEAN regional rules at import (practical interpretation).
II. Legal basis
| Regulation | Reference No. | Date | Provisions |
|---|---|---|---|
| Law on the Management of Pharmaceuticals | Royal Kret of 17 June 1996 | 17 June 1996 | Article 8(1): the import, export and storage of pharmaceuticals and the import of raw materials require Ministry of Health authorisation |
| Amendment Law on the Management of Pharmaceuticals | Royal Kret No. NS/RPhM/1207/037 | Adopted 8 November 2007 | Article 8 (new) 1: the import of pharmaceuticals, raw materials, packaging materials and pharmaceutical machinery requires Ministry of Health authorisation |
| Amendment Law on the Management of Pharmaceuticals | Same | Same | Article 8 (new) 2: import, distribution and display for sale in Cambodia require a Ministry of Health registration number |
| Prakas No. 1258 on the Registration of Medical Devices | Prakas No. 1258 | 8 November 2012 | Only registered devices may be imported and sold |
III. Expert commentary
- The “registration number” and the “import licence” are two independent procedures on entirely different rhythms. The registration number is obtained once and is valid for three years (see article 37); the import licence is processed per consignment. If supply chain scheduling assumes that holding the certificate is enough to ship, the first shipment will get stuck.
- Consistency between documents is the practical risk point at clearance. If product descriptions or model numbers on the commercial invoice differ from the import licence, customs will require an amended declaration and demurrage charges follow. Because Cambodia does not allow product grouping and each model is registered separately, the model list is long in itself; item-by-item checking between invoice and licence should not be underestimated.
- HS code classification affects both duty rates and release speed. Medical devices have specific HS codes in Cambodia; correct classification smooths clearance, while misclassification not only affects duty but may trigger goods inspection. Complete a pre-confirmation of the classification before the first shipment is despatched (practical interpretation).
IV. Practical recommendations
- Build the per-shipment import licence into the pre-despatch standard operating procedure. In sales contracts or despatch notices, make “import licence obtained” a release precondition rather than something to fix after arrival.
- Create a single-source mechanism linking model master data to document generation. Generate the registration certificate list, the import licence application, the commercial invoice and the packing list from the same model master data to avoid manual entry differences.
- Complete HS code pre-confirmation and document pre-review ahead of the first shipment. Engage an experienced customs broker to pre-review the full document set; this materially reduces demurrage risk on the first shipment (practical interpretation).
V. Verification checklist
- □ Product registration certificate obtained and within its validity period
- □ Import licence for each consignment obtained before despatch
- □ Customs documents complete (registration certificate, import licence, invoice, packing list, certificate of origin)
- □ Product descriptions and model numbers match item by item between invoice and import licence
- □ HS code classification pre-confirmed
- □ Document pre-review completed for the first shipment
Regulatory information verified as of 29 October 2026.
In Southeast Asia, GRZAN’s core capabilities focus on three areas. First, tracking the legislative progress of dedicated medical device laws across member states: Singapore, Malaysia, Thailand, Indonesia, the Philippines and Vietnam have each established written device regulatory frameworks, while Cambodia still has no dedicated Medical Device Law; the current rules are pieced together from three layers — the registration-number legal basis provided by the 1996 Law on the Management of Pharmaceuticals and its 2007 Amendment Law, the classification and procedures provided by Prakas No. 1258 of 2012, and the technical framework provided by the ASEAN Medical Device Directive (AMDD) — so compliance certainty is markedly lower than in markets that have completed legislation. Second, local authorised representative services: GRZAN acts as the manufacturer’s statutory representative in Cambodia, handling registration submissions, regulatory communication and post-market reporting obligations, and helping resolve the practical issues of the Cambodian registered pharmacist and the Import-Export Pharmaceutical Company Licence. Third, quality system and testing support: establishing a quality management system conforming to ISO 13485 and organising the technical dossier under the ASEAN Common Submission Dossier Template (CSDT).
Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us